Recombinant Expression SystemsTechnology Investment Opportunities (Technical Insights)

 


Recombinant expression systems are one of the key platforms in cell and molecular biology research, diagnostics, and development of therapeutics. These systems have been in existence for over two decades but have lately come into prominence due to the use of novel hosts for transfection, such as transgenic plants, protozoa, and algae. The technology platforms being developed in this sector feature both breakthrough and incremental innovations, making it a key driver of industry dynamics.

Regular Price: USD 4,950

Special Price USD 3,713

25% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,713

PAY BY INVOICE

Be the first to review this product

Table of Contents

Recombinant Expression Systems—Technology Investment Opportunities (Technical Insights), Advances in Recombinant Expression SystemsTechnology Investment Opportunities Recombinant Expression Systems--Technology Investment Opportunities




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.